论文部分内容阅读
目的评价舒泰清(聚乙二醇电解质散剂)联合莫沙比利治疗阿片制剂引起便秘的疗效。方法116例阿片制剂引起的便秘患者口服莫沙比利5 mg,3次/d+舒泰清13.701 g,2次/d;分别于第2周和第4周观察患者治疗情况和药物不良反应。结果治疗2周和4周显效率分别为46.6%和67.2%,总有效率分别为76.7%和85.3%,治疗期间未发生明显不良反应。结论莫沙比利联合舒泰清治疗阿片制剂引起便秘安全、有效。
Objective To evaluate the efficacy of Shu Taiqing (polyethylene glycol electrolyte powder) combined with mosapride in the treatment of opioids causing constipation. Methods 116 cases of constipation caused by opiates were treated with mosapride 5 mg, 3 times / d and shuetaiqing 13.701 g twice daily for 2 weeks and 4 weeks respectively. The treatment and adverse drug reaction were observed. Results The effective rates of two weeks and four weeks after treatment were 46.6% and 67.2%, respectively. The total effective rates were 76.7% and 85.3% respectively. No obvious adverse reactions occurred during the treatment. Conclusion Mosapride combined with Shutaiqing opioids caused constipation is safe and effective.